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Abstract
Background: Although cyclooxygenases (COX) and prostaglandin E synthases (PGES) have been implicated in
ischemic stroke injury, little is known about their role in intracerebral hemorrhage (ICH)-induced brain damage. This
study examines the expression and cellular localization of COX-1, COX-2, microsomal PGES-1 (mPGES-1), mPGES-2,
and cytosolic PGES (cPGES) in mice that have undergone hemorrhagic brain injury.
Methods: ICH was induced in C57BL/6 mice by intrastriatal injection of collagenase. Expression and cellular
localization of COX-1, COX-2, mPGES-1, mPGES-2, and cPGES were examined by immunofluorescence staining.
Results: In the hemorrhagic brain, COX-1, mPGES-2, and cPGES were expressed constitutively in neurons; COX-1
was also constitutively expressed in microglia. The immunoreactivity of COX-2 was increased in neurons and
astrocytes surrounding blood vessels at 5 h and then tended to decrease in neurons and increase in astrocytes at
1 day. At 3 days after ICH, COX-2 was observed primarily in astrocytes but was absent in neurons. Interestingly, the
immunoreactivity of mPGES-1 was increased in neurons in the ipsilateral cortex and astrocytes in the ipsilateral
striatum at 1 day post-ICH; the immunoreactivity of astrocytic mPGES-1 further increased at 3 days.
Conclusion: Our data suggest that microglial COX-1, neuronal COX-2, and astrocytic COX-2 and mPGES-1 may
work sequentially to affect ICH outcomes. These findings have implications for efforts to develop anti-inflammatory
strategies that target COX/PGES pathways to reduce ICH-induced secondary brain damage.
Background
Intracerebral hemorrhage (ICH) is a subtype of stroke
that carries high morbidity and mortality. ICH causes
brain injury through primary physical disruption of adja-
cent tissue and the mass effect and secondary injury
such as brain edema and inflammation [1,2]. Evidence
from preclinical and clinical studies suggests that
inflammatory mechanisms contribute to the progression
of secondary brain injury after ICH [1,3]. Inflammatory
cells that have the potential to promote hemorrhagic
brain damage include blood-derived leukocytes and
macrophages, resident microglia, astrocytes, and mast
cells. Molecular components of the inflammatory
response include prostaglandins, chemokines, cytokines,
extracellular proteases, and reactive oxygen species
[3-5].
Prostaglandin E2 (PGE2) is a key component in the
initiation and propagation phases of the inflammatory
process induced after various types of brain injury [6-8].
It is synthesized from arachidonic acid in two enzymatic
steps. Cyclooxygenase (COX) catalyzes the conversion of
arachidonic acid to PGH2, which is then converted to
PGE2 by PGE synthase (PGES). COX is present in two
isoforms, constitutive COX-1 and inducible COX-2.
Under normal conditions, COX-1, which is expressed in
numerous tissues, has been classically considered to be
the isoform principally responsible for homeostatic pros-
taglandin synthesis [9]. In contrast, COX-2 is primarily
expressed in glutamatergic neurons, wherein it is thought
to participate in synaptic signaling [10]. Three major iso-
zymes of PGES have been isolated: microsomal PGES
(mPGES)-1, mPGES-2, and cytosolic PGES (cPGES). Of
these, mPGES-2 and cPGES are constitutively expressed
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in various cells and tissues; only mPGES-1 can be
induced by pro-inflammatory stimuli and in ischemic
stroke models [7,11-13]. A recent study showed that
COX-2 and mPGES-1 are co-induced by excess gluta-
mate in ischemic brain and that they act together to
exacerbate stroke injury by amplifying PGE2 production
[14].
Although COX/prostaglandin signaling has been
implicated in the pathologic progression of ischemic
stroke [15-17], research on their role in ICH is limited.
To our knowledge, no reports have been published
regarding expression of COX-1 and PGES isoforms in
ICH. Two studies have been published on COX-2
expression in blood models of ICH in rats, but the
results are conflicting. One showed COX-2 immunor-
eactivity to be increased from 6 h to 3 days after ICH
[18], whereas the second showed a transient increase in
COX-2 from 1 to 3 h after ICH followed by a significant
down-regulation [19]. To lay a foundation for under-
standing the roles of COX and PGES isoforms in ICH
pathology, here we characterized the expression and
cellular localization of COX-1, COX-2, mPGES-1,
mPGES-2, and cPGES from 5 h to 3 days after collage-
nase-induced ICH in mice.
Materials and methods
Animals
This study was conducted in accordance with the
National Institutes of Health guidelines for the use of
experimental animals. Experimental protocols were
approved by the Johns Hopkins University Animal Care
and Use Committee. A total of 56 C57BL/6 male mice
(25-35 g) were obtained from Charles River Laboratories
(Wilmington, MA). All efforts were made to minimize
the numbers of animals used and ensure minimal
suffering.
ICH model
The procedure for modeling ICH by intrastriatal injec-
tion of collagenase was adapted to mice from an estab-
lished rat protocol [20] and has been described
previously [21,22]. Briefly, C57BL/6 mice weighing
22-35 g were anaesthetized by isoflurane (3.0% for
induction, 1.0% for maintenance) and ventilated with
oxygen-enriched air (20%:80%) via a nose cone. We then
injected mice in the left striatum with collagenase VII-S
(0.075 U in 500 nL saline, C2399, Sigma, St. Louis, MO)
at the following stereotactic coordinates: 1.0 mm ante-
rior and 2.2 mm lateral of the bregma, 2.7 mm in depth.
Collagenase was delivered over 5 min. The needle was
held in place for an additional 5 min to prevent reflux.
Sham-operated mice were injected with saline only. Rec-
tal temperature was monitored and maintained at 37.0 ±
0.5°C with a heating pad throughout the experimental
and recovery periods. This procedure resulted in repro-
ducible lesions that were mostly restricted to the
striatum.
Preparation of brain slices
At 5, 24, or 72 h after ICH, 3 mice per group were
anesthetized deeply with phenobarbital and perfused
transcardially with phosphate-buffered saline (PBS), pH
7.4. Sham-operated control mice (n = 2 at each time
point) were perfused similarly. The brains were har-
vested and fixed with 4% paraformaldehyde overnight,
cryoprotected in serial phosphate-buffered sucrose solu-
tions (20%, 30%, and 40%) at 4°C, and then cut into
20-μm sections with a cryostat.
Hemorrhagic injury volume
Mice (n = 5) were euthanized at 24 h after ICH. The
entire brain of each mouse was cut into 50-μm sections
with a cryostat. Sections were stained with Luxol fast
blue (for myelin) and Cresyl Violet (for neurons) before
being quantified for grey and white matter injury with
SigmaScan Pro software (version 5.0.0 for Windows;
Systat, San Jose, CA). The injury volume in cubic milli-
meters was calculated by multiplying the thickness by
the damaged areas of each section [21].
Immunofluorescence
Immunofluorescence was carried out as described pre-
viously [23,24]. Briefly, free-floating sections were
washed in PBS for 20 min, blocked in 5% normal goat
serum, and incubated overnight at 4°C with primary
antibodies: rabbit anti-COX-1 (1:250; Catalog No.
160109, Cayman Chemical, Ann Arbor, MI); rabbit anti-
COX-2 (1:250; Catalog No. 160106, Cayman Chemical);
rabbit anti-mPGES-1 (1:250; Catalog No. 160140, Cay-
man Chemical); rabbit anti-mPGES-2 (1:250; Catalog
No. 160145, Cayman Chemical); rabbit anti-cPGES
(1:250; Catalog No. 10209, Cayman Chemical); mouse
anti-NeuN (1:500; Catalog No. MAB377, Chemicon,
Temecula, CA), specific for neurons; rat anti-GFAP
(1:250; Catalog No. 13-0300, Invitrogen, Carlsbad, CA),
specific for astrocytes; and rat anti-CD11b (1:1000; Cata-
log No. MCA711G, Serotec, Raleigh, NC), specific for
microglia/macrophages. The sections were then washed
with PBS and incubated with Alexa-488 (1:1000; Mole-
cular Probes, Eugene, OR)- and/or Cy3 (1:1000; Jackson
Labs, West Grove, PA)-conjugated secondary antibodies
for 60 min. Stained sections (n = 3/mouse) were exam-
ined with a fluorescence microscope; the images were
captured from the frontoparietal cortex and striatum
and analyzed by SPOT advanced image software (Diag-
nostic Instruments Inc., Sterling Heights, MI). Control
sections were processed identically, except that primary
antibodies were omitted. Control sections lacked specific
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staining. The specificity of the antibodies against COX-
1, COX-2, mPGES-1, mPGES-2, and cPGES was further
confirmed by using the corresponding blocking peptides
(Cayman Chemical).
To quantify the number of immunoreactive cells
labeled with COX-1, COX-2, mPGES-1, mPGES-2, and
cPGES, three sections per mouse (from the injection
site and 360 μm on each side; n = 3 mice/group) were
analyzed in the perihematoma region of the striatum.
This region was defined within one 20× field that cor-
responded to ~460 μm from the edge of the hema-
toma. Positively stained cells were counted in three
comparable, randomly selected 30× microscopic fields.
The numbers of immunoreactive cells from nine loca-
tions per mouse (3 fields per section × 3 sections per
mouse) were averaged and expressed as positive cells
per field (30×).
Statistics
All data are expressed as means ± SD. The statistical
comparisons among multiple groups were made using
one-way ANOVA followed by Bonferroni correction.
Statistical significance was set at P < 0.05.
Results
Brain injury volume
Collagenase injection produced a hematoma that was
primarily restricted to the striatum. All mice displayed
obvious neurobehavioral deficits within hours of ICH
onset (i.e., ipsilateral turning bias). At 24 h after ICH,
the brain injury volume calculated from serial sections
stained with Luxol fast blue/Cresyl Violet via an image
analysis system was 7.5 ± 1.6 mm3 (n = 5).
Expression of COX-1 and COX-2 after ICH
COX-1 immunoreactivity was primarily observed in
neuron-like and glia-like cells in the contralateral and
ipsilateral striatum (figure 1A) and did not change sig-
nificantly from 5 h to 3 days after ICH (figure 1A-D).
To determine the cellular location of COX-1 following
ICH, we double stained serial sections obtained 3 days
after ICH for COX-1 and cell-specific antigens. The
results revealed that COX-1 immunoreactivity was
mostly associated with neurons (figure 1B) and micro-
glia (figure 1C). Co-localization was not observed with
GFAP, a marker for astrocytes (figure 1D). Cell count
analysis confirmed that the number of COX-1-immu-
noreactive neurons and microglia did not change from
5 h to 3 days in the perihematomal region of the stria-
tum (figure 1E, n = 3/group, all P > 0.05).
Immunoreactivity for COX-2 in neuron-like and glia-
like cells was minimal in the contralateral striatum
(figure 2). After ICH, the number of COX-2-immunor-
eactive cells increased in the perihematomal region of
the striatum; the increase was present at 5 h and contin-
ued at 3 days, a finding confirmed by quantification ana-
lysis. COX-2-immunoreactive astrocytes displayed
increasing hypertrophy of the cell bodies and processes
from 5 h to 3 days after ICH (insets in figure 2). In the
perihematomal region of the striatum, the immunoreac-
tivity of COX-2 was significantly increased in neurons
and astrocytes surrounding blood vessels at 5 h. The
Figure 1 Immunostaining of COX-1 and cell type-specific
proteins in the mouse brain after ICH. A: COX-1 was
constitutively expressed in the contralateral striatum (CL) and did
not change significantly from 5 h to 1 day after ICH. The insets in
A are representative COX-1-expressing cells at higher
magnification (Scale bar, 10 μm). B-D: Double immunostaining of
COX-1 with cell type-specific markers for neurons (NeuN),
microglia (CD11b), and astrocytes (GFAP) in the striatum
surrounding the hematoma at 3 days after ICH. Insets in B and C
show a double-stained cell at higher magnification (Scale bar, 10
μm). Scale bar in the middle panels of B, C, D, 30 μm. E:
Quantification analysis confirmed that the number of COX-1-
immunoreactive neurons and microglia did not change in the
perihematomal region of the striatum from 5 h to 3 days after ICH
(n = 3/group, all P > 0.05). Values are means ± S.D.
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intensity tended to decrease in neurons and increase in
astrocytes at 1 day after ICH. At 3 days, the immunor-
eactivity of COX-2 continued to increase in astrocytes
but was nearly undetectable in neurons (figure 3). COX-
2 immunoreactivity was not detected in microglia at any
time point studied (figure 3).
Expression of mPGES-1, mPGES-2, and cPGES after ICH
Minimal immunoreactivity of mPGES-1 was observed in
neuron-like cells in the contralateral cortex (data not
shown) and striatum (figure 4A). In the perihematomal
region, the immunoreactivity of mPGES-1 began to
increase in glia-like cells at 1 day (figure 4C) and was
further increased at 3 days after ICH (figure 4D). In the
ipsilateral cortex, mPGES-1 immunoreactivity was
Figure 2 Immunostaining of COX-2 in the mouse brain after
ICH. Minimal COX-2 immunoreactivity was observed in neuron-like
and glia-like cells in the contralateral striatum (CL). After ICH, the
number of strongly COX-2-immunoreactive cells increased in the
perihematomal region of the striatum; the increase started at 5 h
and continued at 3 days. Scale bar, 30 μm. Insets are representative
COX-2-expressing cells at higher magnification (Scale bar, 15 μm).
Quantification analysis confirmed that the number of strongly COX-
2-immunoreactive cells increased from 5 h to 3 days in the
perihematomal region of the striatum (n = 3/group, * P < 0.05,
** P < 0.01 compared with the CL, # P < 0.01 compared with the
previous time point). Values are means ± S.D.
Figure 3 Double immunostaining of COX-2 with cell type-
specific markers (NeuN for neurons, CD11b for microglia, and
GFAP for astrocytes) in the mouse brain after ICH. A-C: In the
perihematomal region of the striatum, the number of COX-2-
immunoreactive cells increased; double immunostaining
demonstrated that COX-2 was expressed in neurons (A) and
astrocytes (C), but not in microglia (B), at 5 h after ICH. D-F: At 1
day after ICH, the COX-2 immunoreactivity tended to decrease in
neurons (D) and increase in astrocytes (F) of the perihematomal
region in the striatum; however COX-2 immunoreactivity remained
unchanged in microglia (E). G-I: At 3 days post-ICH, COX-2
immunoreactivity further increased in astrocytes (I) but was not
observed in neurons (G) or microglia (H) in the perihematomal
region of the striatum. Scale bar in C, F, I, 30 μm.
Wu et al. Journal of Neuroinflammation 2011, 8:22
http://www.jneuroinflammation.com/content/8/1/22
Page 4 of 8
observed primarily in neurons (figure 4E), infrequently
in astrocytes (data not shown), and rarely in microglia/
macrophages (figure 4F) at 1 day after ICH. In the ipsi-
lateral striatum, however, mPGES-1 immunoreactivity
was detected primarily in astrocytes; it was elevated at 1
day (figure 4G) and further increased at 3 days (figure
4H), as confirmed by quantification analysis (Figure 4I).
mPGES-1 was not detected in neurons (data not
shown).
mPGES-2 was constitutively expressed in neuron-like
cells in the contralateral and ipsilateral striatum (figure
5A-D) and did not change significantly between 5 h and
3 days after ICH (figure 5B-D). Double immunofluores-
cence labeling revealed that the mPGES-2 was located
primarily in neurons at 5 h after ICH (figure 5E) but
that it was absent from microglia/macrophages at 1 day
(figure 5F) and astrocytes at 3 days (figure 5G) after
ICH. Cell count analysis confirmed that the number of
mPGES-2-immunoreactive cells did not change from 5
h to 3 days in the perihematomal region of the striatum
(figure 5H, n = 3/group, all P > 0.05).
Similar to mPGES-2, immunostaining revealed cPGES
to be expressed constitutively in neuron-like cells in the
contralateral and ipsilateral striatum (figure 6A-C); it
did not change significantly between 1 and 3 days after
ICH (figure 6B-C). Double immunofluorescence labeling
indicated that cPGES was present primarily in neurons
(figure 6D), but not in microglia/macrophages (figure
6E) or astrocytes (figure 6F) at 1 day after ICH. Cell
count analysis confirmed that the number of cPGES-
immunoreactive cells did not change from 1 day to 3
days in the perihematomal region of the striatum (figure
6G, n = 3/group, all P > 0.05).
Discussion
To our knowledge, this is the first systematic study per-
formed to characterize the expression and cellular locali-
zation of COX and PGES isozymes in the hemorrhagic
brain of mice. Using immunofluorescence staining, we
observed constitutive expression of COX-1, mPGES-2,
and cPGES in neurons; COX-1 was also constitutively
expressed in microglia. In contrast, COX-2 and mPGES-
1 immunoreactivity, which was minimal in the normal
brain, underwent distinct time-dependent changes in
neurons and astrocytes of the perihematomal region
during the first 3 days post-ICH. Our data support the
premise that the COX/PGES signaling pathway contri-
butes to ICH pathology.
COX-1 is constitutively expressed in most tissues [9].
We demonstrated for the first time that COX-1 is con-
stitutively expressed in neurons and microglia in the
hemorrhagic brain. Although involvement of COX-1 in
ICH pathology has not been studied, the evidence that
COX-1 is produced in microglia of the perihematomal
Figure 4 Immunostaining of mPGES-1 and cell type-specific
proteins (NeuN for neurons, CD11b for microglia, and GFAP
for astrocytes) in the mouse brain after ICH. (A) Minimal
immunoreactivity of mPGES-1 was detected in neuron-like cells in
the contralateral striatum (CL). B-D: In the perihematomal region of
the striatum, mPGES-1 immunoreactivity was undetectable at 5 h
(B) but began to increase in glia-like cells at 1 day (C). It was
additionally increased in glia-like cells at 3 days (D). Insets in A, C,
and D are representative mPGES-1-expressing cells at higher
magnification (Scale bar, 15 μm). E-F: Double immunostaining
showed induction of mPGES-1 in neurons (E), but not in microglia
(F), in the ipsilateral frontal-parietal cortex at 1 day. G-H: In the
perihematomal region of the striatum, double immunostaining
showed that mPGES-1 was induced primarily in astrocytes at 1 day
(G); the number of mPGES-1-immunoreactive astrocytes was
additionally increased at 3 days (H). Scale bar in D-H, 30 μm. Insets
in E, G, and H are double-stained cells at higher magnification (Scale
bar, 15 μm). Quantification analysis (I) confirmed that the number of
mPGES-1 immunoreactive cells increased at 1 day, and further
increased at 3 days in the perihematomal region of the striatum
(n = 3/group, * P < 0.05, ** P < 0.01 compared with the CL,
# P < 0.01 compared with day 1). Values are means ± S.D.
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region implies a toxic role of COX-1 in the pathophy-
siology of the disease. This hypothesis is based on the
fact that activated microglia/macrophages are the major
sources of proinflammatory mediators [1,3] and that
inhibition of microglial activation before or early after
ICH decreases neuronal death and improves neurologic
function [21,25]. We therefore propose that microglial
COX-1 might immediately initiate synthesis of prosta-
glandins in response to microglial activation and could
be considered one of the major players in mediating
neuroinflammation after ICH.
In the normal brain, COX-2 is constitutively expressed
in neurons of the cortex, hippocampus, and striatum [8].
COX-2 is mainly induced in response to inflammatory
stimuli; deletion of the COX-2 gene or selective COX-2
inhibition reduces infarction volume and neuronal death
after cerebral ischemia [26-28]. To our knowledge, only
two studies have investigated post-ICH COX-2
Figure 6 Immunostaining of cPGES and cell type-specific
proteins (NeuN for neurons, CD11b for microglia, and GFAP
for astrocytes) in the mouse brain after ICH. A: Immunoreactive
staining for cPGES was observed in neuron-like cells in the
contralateral striatum (CL). B-C: In the perihematomal region of the
striatum, cPGES immunoreactivity did not change significantly
between 1 day (B) and 3 days (C). D-F: In the perihematomal region
of the striatum, double immunostaining showed that cPGES was
present in neurons (D), but not in microglia (E) or astrocytes (F), at
1 day. Scale bar in B-F, 30 μm. Inset in D is a double-stained cell at
higher magnification (Scale bar, 15 μm). Quantification analysis (G)
confirmed that the number of cPGES immunoreactive cells did not
change in the perihematomal region of the striatum between 1 day
and 3 days after ICH (n = 3/group, all P > 0.05). Values are
means ± S.D.
Figure 5 Immunostaining of mPGES-2 and cell type-specific
proteins (NeuN for neurons, CD11b for microglia, and GFAP
for astrocytes) in the mouse brain after ICH. A: Immunoreactive
staining for mPGES-2 was observed in neuron-like cells in the
contralateral striatum (CL). B-D: In the perihematomal region of the
striatum, mPGES-2 immunoreactivity did not change significantly
between 5 h (B) and 1 day (C) or 3 days (D) post-ICH. E-G: In the
perihematomal region of the striatum, double immunostaining
revealed that mPGES-2 was present in neurons at 1 day (E), but not
in microglia at 1 day (F) or astrocytes at 3 days (G). Scale bar in D-G,
30 μm. Inset in E is a double-stained cell at higher magnification
(Scale bar, 20 μm). Quantification analysis (H) confirmed that the
number of mPGES-2-immunoreactive cells did not change in the
perihematomal region of the striatum from 5 h to 3 days after ICH
(n = 3/group, all P > 0.05). Values are means ± S.D.
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expression, and the results were conflicting [18,19].
Zhao et al. [19] demonstrated that COX-2 mRNA and
protein were increased within 3 h after ICH and that
COX-2 immunoreactivity was increased in blood vessels
and neurons in the perihematomal region at 4 h; the
increase in immunoreactivity was transient, followed by
a significant down-regulation at days 1 and 3. In the
present study, we found that the immunoreactivity of
COX-2 in astrocytes increased gradually in the perihe-
matomal region from 5 h to 3 days, whereas neuronal
COX-2 increased only transiently at 5 h after ICH. Most
of our results are consistent with the findings by Gong
et al. [18], except that we found COX-2 to be increas-
ingly induced in astrocytes from 1 to 3 days, whereas
Gong et al. reported that COX-2 was induced in
endothelial cells, perivascular cells, and infiltrating leu-
kocytes at 1 day after blood infusion. The reason for the
discrepancy between the previous studies and our own
is not clear, but it may be a result of differences in ICH
models and species used and the size of the intrastriatal
hematoma formed. In the two previous studies, investi-
gators modeled ICH by injecting rats intrastriatally with
differing amounts of autologous blood. In contrast, we
used a collagenase-induced ICH model in mice that may
cause gradual hematoma growth over the first few hours
with subsequent inflammation. Our data suggest that
astrocytic COX-2 in concert with microglial COX-1
might contribute to collagenase-induced post-hemorrha-
gic neuroinflammation. More studies are warranted to
understand whether the functions of neuronal and
astrocytic COX-2 differ after ICH.
Induction of mPGES-1 expression has been observed
in various conditions, such as inflammation, fever, pain,
tissue repair, and cancer, in which COX-2-derived PGE2
plays a critical role [29]. In the ischemic brain, mPGES-
1 and COX-2 are both induced in neurons, microglia,
and endothelial cells in the ipsilateral cerebral cortex
and striatum [7]. It has been confirmed that mPGES-1
and COX-2 are co-localized and co-induced in the
infarct region of the cortex, and it has been suggested
that they act together to exacerbate stroke injury [14].
At 1 day post-ICH in our model, mPGES-1 expression
in the ipsilateral cortex was elevated primarily in neu-
rons whereas in the perihematomal region, it was ele-
vated in astrocytes. Astrocytic expression continued to
increase for at least 3 days. However, we observed no
apparent changes in the expression of neuronal mPGES-
2 or cPGES. The different cellular expression profiles
for mPGES-1 between cortex and striatum suggests that
mPGES-1 may be involved in different signaling path-
ways within the cortical neurons and striatal astrocytes
after ICH. In line with the results from a lipopolysac-
charide-induced inflammation model [30], we found
that the induction of COX-2 protein expression was
more rapid than that of mPGES-1 in the hemorrhagic
brain. These results suggest that the sequential up-regu-
lation and co-induction of COX-2 and mPGES-1 in
astrocytes in the perihematomal region might contribute
to inflammation-mediated secondary brain injury after
ICH, possibly through excessive PGE2 production.
In conclusion, our data provide novel evidence that
COX-1, mPGES-2, and cPGES are constitutively
expressed in the hemorrhagic brain; COX-2 is induced
early in neurons and later in astrocytes. Although neu-
ronal COX-2 is induced earlier than astrocytic COX-2,
the latter is induced in parallel with astrocytic mPGES-
1. Together, our data suggest that microglial COX-1,
neuronal COX-2, astrocytic COX-2, and astrocytic
mPGES-1 may work sequentially to affect ICH out-
comes. Based on our previous observations that neu-
roinflammation affects the normal function of the entire
brain in patients with lethal ICH [31], these findings
have implications for efforts to develop anti-inflamma-
tory strategies that target the COX/PGES pathway to
reduce ICH-induced secondary brain damage. Indeed, a
recent study showed that inhibition of COX-2 attenu-
ated inflammation, neuronal death, and gliosis and pro-
moted long-term recovery in motor function and
myelination in rabbit pups with intraventricular hemor-
rhage [32].
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